ESOP Share Allotment Details:
- The company allotted 1,46,300 equity shares to eligible employees of the company and its subsidiary companies
- The allotment was made pursuant to exercise of options vested under the Employee Stock Option Scheme 2025 (HFL ESOS 2025)
- Face value: ₹2 per share
- Exercise price: Not explicitly stated for the allotted shares
Change in Paid-up Share Capital:
- Previous capital: ₹24,23,25,404 (24.23 crore rupees) consisting of 12,11,62,702 equity shares of ₹2 each
- New capital: ₹24,26,18,004 (24.26 crore rupees) consisting of 12,13,09,002 equity shares of ₹2 each
- Increase of ₹2,92,600 in paid-up capital
ESOP Scheme Compliance:
- Scheme name: HFL ESOS 2025 (Employee Stock Option Scheme 2025)
- Compliance reference: SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
- The shares rank pari-passu with existing equity shares (implied by capital structure change)
Fresh ESOP Grant Details:
- The committee granted fresh 1,05,900 stock options to eligible employees
- Exercise price per option: ₹2 (face value of shares as on September 18, 2026)
- Vesting period: Options vest after 1 year but not later than 9 years from grant date
- Exercise period: 5 years from vesting date while in employment
- No lock-in period for shares allotted upon exercise
Regulatory Compliance:
- Disclosure made pursuant to Regulation 30 read with Para B of Part A of Schedule III of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015
- Additional compliance with SEBI circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024
- Additional compliance with SEBI circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024
Meeting Details:
- Nomination and Remuneration Committee meeting held on Friday, September 18, 2026
- Meeting commenced at 4:00 p.m. and concluded at 4:20 p.m.
Additional Announcements:
No additional corporate updates were included in this filing beyond the ESOP allotment and grant activities.